ZYXI Zynex Dashboard

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. The company also develops a new blood volume monitor for use in hospitals and surgery centers. Zynex was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.

Company profile

Ticker

ZYXI

Exchange

NASDAQ

Website

www.zynex.com

CEO

Thomas Sandgaard

Incorporated

Nevada

Location

Colorado

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Electromedical & Electrotherapeutic Apparatus

Medtronic • Varian Medical Systems • Conmed • Natus Medical • Masimo • LivaNova • Outset Medical • Fonar • Cutera • Inmode ...

Former names

ARIZONA VENTURES INC, CHINA GLOBAL DEVELOPMENT INC, FOX RIVER HOLDINGS INC, IBONZAI COM INC, LIFE MEDICAL TECHNOLOGIES INC /UT/, ZYNEX MEDICAL HOLDINGS INC, ZYNEX MEDICAL HOLDINGS INC

SEC CIK

0000846475

Corporate docs

Articles of Incorporation & Bylaws

IRS number

870403828

ZYXI stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2021

9 Mar 21

Northland Capital Markets Upgrades Zynex to Outperform

9 Mar 21

Northland Capital Markets analyst James Terwilliger upgrades Zynex (NASDAQ:ZYXI) from Market Perform to Outperform.

Zynex Announces $10M Buyback

8 Mar 21

ENGLEWOOD, Colo., March 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain

72 Biggest Movers From Friday

1 Mar 21

12 Health Care Stocks Moving In Friday's Intraday Session

26 Feb 21

Press releases

Pro users get this 30m faster

Zynex Announces 140% Year over Year Order Growth in Q1-2021

12 Apr 21

ENGLEWOOD, Colo., April 12, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke

Zynex Growth Leads to New Corporate Headquarters

9 Apr 21

ENGLEWOOD, Colo., April 9, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke

Zynex Recognized as the Sixth Largest Biotechnology/Bioscience Company in Colorado

30 Mar 21

ENGLEWOOD, Colo., March 30, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke

Zynex Announces Share Buyback Program

8 Mar 21

Zynex Announces 2020 Fourth Quarter and Full Year Earnings

25 Feb 21

Calendar

25 Feb 21

13 Apr 21

31 Dec 21

Financial summary

Financial statements Chart ZYXI financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Zynex earnings reports.

Recent insider trades

ZYXI insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
8 Apr 21	Daniel J Moorhead	Common Stock	Payment of exercise	Dispose F	No	No	15.25	1,156	17.63K	33,343
5 Mar 21	Daniel J Moorhead	Common Stock	Payment of exercise	Dispose F	No	No	14.75	1,359	20.05K	31,374
5 Mar 21	Daniel J Moorhead	Common Stock (Restricted Stock Award)	Grant	Aquire A	No	No	0	5,000	0	99,949
25 Feb 21	Daniel J Moorhead	Common Stock (Restricted Stock Award)	Grant	Aquire A	No	No	0	3,767	0	98,699
5 Feb 21	Daniel J Moorhead	Common Stock	Payment of exercise	Dispose F	No	No	19	399	7.58K	28,983
4 Feb 21	Daniel J Moorhead	Common Stock	Payment of exercise	Dispose F	No	No	18.16	213	3.87K	28,440

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

ZYXI institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

38.6% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	125	137	-8.8%
Opened positions	21	36	-41.7%
Closed positions	33	27	+22.2%
Increased positions	42	59	-28.8%
Reduced positions	40	24	+66.7%

13F shares	Current	Prev Q	Change
Total value	255.41M	293.17M	-12.9%
Total shares	13.45M	12.1M	+11.2%
Total puts	436.5K	202.2K	+115.9%
Total calls	417.6K	131.8K	+216.8%
Total put/call ratio	1.0	1.5	-31.9%

Largest owners	Shares	Value	Change
BLK Blackrock	2.9M	$39.04M	+5.5%
Sandgaard Thomas	1.3M	$17.02M	NEW
Hood River Capital Management	1.14M	$15.36M	+1552.5%
Vanguard	1.11M	$14.93M	-15.7%
STT State Street	515.9K	$6.94M	+1.4%
Punch & Associates Investment Management	430.88K	$5.8M	+5.2%
Nuveen Asset Management	329.38K	$4.43M	+3.8%
Geode Capital Management	298.45K	$4.02M	+9.3%
Capital Impact Advisors	275.53K	$3.71M	+40.8%
Millennium Management	266.84K	$3.59M	+33.2%

Largest transactions	Shares	Bought/sold	Change
Sandgaard Thomas	1.3M	+1.3M	NEW
Hood River Capital Management	1.14M	+1.07M	+1552.5%
WFC Wells Fargo & Co.	63.56K	-281.47K	-81.6%
Next Century Growth Investors	0	-241.21K	EXIT
Vanguard	1.11M	-206.72K	-15.7%
JPM JPMorgan Chase & Co.	192.61K	+163.46K	+560.7%
BLK Blackrock	2.9M	+150.1K	+5.5%
Intrinsic Edge Capital Management	0	-142.87K	EXIT
Calamos Advisors	44.11K	-129.79K	-74.6%
Susquehanna International	251.51K	+127.15K	+102.2%

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accommodate, accuracy, alter, Anna, behavior, catalog, chain, Compark, constraint, CW, demo, Deprecation, dissolution, dissolved, embodied, explore, FDIC, foster, foundation, GIG, human, infrastructure, instrumental, invoice, layer, legend, Lucsok, mindset, navigate, outbreak, pandemic, population, promote, promotion, pronouncement, proportional, provisional, recalculation, rep, restart, sample, Sandler, spread, surgical, talented, tariff, tuition, unconditional, underserved, underwritten, widespread, workforce, world

Removed: adjustment, advertising, afforded, Arab, Arabia, Australia, beneficially, Bulletin, buyback, Canada, capitalized, carried, carryback, China, clarify, compensate, Concurrent, conscientiously, consecutive, consistent, controlling, damaged, deficit, depict, detected, detection, Egypt, enactment, entity, excise, extraordinarily, feedback, finalize, finalized, fulfill, function, generic, Germany, healthy, HMO, Holland, impaired, impede, India, initiate, insignificant, involving, Joachim, kroner, learn, liquidation, low, Malaysia, merger, microprocessor, move, NOL, nominating, notice, offered, partially, penetrate, permit, placement, PPO, precluded, principally, productivity, profitable, promissory, qualify, qualitative, quantitative, realization, recertification, recognizing, recording, reflect, relearning, release, Removal, rental, reserved, responding, restored, retrospective, reward, Russia, SAB, Saudi, scheduled, science, show, Singapore, SSB, suffered, takeover, task, TBK, UAE, unaddressed, USD, visible, voice, voting, worker

From filing 10-K 2020 FY